Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (3110)	12/3/1997 3:52:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

**********NEWS FLASH************ Watch for AGPH CEO comments on the newswires. Shocked at price drop. Offers further comments. Based on his comments, I would almost expect some insider buying. sf

To: David S. who wrote (3110)	12/3/1997 3:57:00 PM
From: Andrew H	Respond to of 6136

I'm against hype, also, David. However, AGPH has been one of the big success stories of development stage biotechs. Even if they only earn $2.14/share in 2000, most biotechs would give their eyeteeth for those earnings. More important, they will be saving a lot of lives. Still, you do make a good point about ice cream sandwiches (:>)